HK-listed Kindstar Globalgene rises most in over 3 months on buyback plan

Kindstar Globalgene Technology

08/11/2021 05:39

** Shares of clinical testing services provider Kindstar
Globalgene Technology Inc  9960.HK  surge 6.7% to HK$4.64, the
biggest daily percentage gain since July 29
    ** Stock on course for the first rise since Oct. 26
    ** Company says it will repurchase shares in the open market
from time to time as appropriate and it will finance the buyback
with its internal resources (https://bit.ly/3BTJ5Fl)
    ** Says its current internal financial resources would
enable it to implement the share repurchase while maintaining a
solid financial position
    ** Hong Kong's healthcare index  .HSCIH  falls 3.8%, and the
Hang Seng Composite Index  .HSCI  slips 0.4%
    ** The Hang Seng China Enterprises Index  .HSCE  eases 0.3%
and the benchmark index  .HSI  slides 0.4%

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))